PROGNOSTIC VALUE OF HIGH-SENSITIVITY MODIFIED GLASGOW PROGNOSTIC SCORE IN CASTRATION-RESISTANT PROSTATE CANCER PATIENTS WHO RECEIVED DOCETAXEL

被引:0
|
作者
Sakamoto, S. [1 ]
Ando, K. [2 ]
Imamura, Y. [1 ]
Kato, M. [3 ]
Komiya, A. [3 ]
Ichikawa, T. [3 ]
机构
[1] Chiba Univ, Grad Sch Med, Chiba, Japan
[2] Chiba Labor Disaster Hosp, Dept Urol, Chiba, Japan
[3] Chiba Univ, Grad Sch Med, Dept Urol, Chiba, Japan
来源
JOURNAL OF SEXUAL MEDICINE | 2022年 / 19卷 / 05期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
124
引用
收藏
页码:S175 / S175
页数:1
相关论文
共 50 条
  • [31] PROGNOSTIC VALUE OF PRETREATMENT LUNG IMMUNE PROGNOSTIC INDEX IN PATIENTS WITH METASTATIC HORMONE-SENSITIVE AND CASTRATION-RESISTANT PROSTATE CANCER
    Wang, Zhipeng
    Liu, Haoyang
    Zhao, Jinge
    Shen, Pengfei
    Zeng, Hao
    JOURNAL OF UROLOGY, 2023, 209 : E218 - E218
  • [32] Prognostic value of pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer
    Wang, Z.
    Liu, H.
    Zhao, J.
    Junru, C.
    Shen, P.
    Zeng, H.
    EUROPEAN UROLOGY, 2023, 83
  • [33] Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysis
    Miura, Noriyoshi
    Mori, Keiichiro
    Mostafaei, Hadi
    Quhal, Fahad
    Motlagh, Reza Sari
    Abufaraj, Mohammad
    Pradere, Benjamin
    Aydh, Abdulmajeed
    Laukhtina, Ekaterina
    D'Andrea, David
    Saika, Takashi
    Shariat, Shahrokh F.
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (11) : 1881 - 1891
  • [34] Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysis
    Noriyoshi Miura
    Keiichiro Mori
    Hadi Mostafaei
    Fahad Quhal
    Reza Sari Motlagh
    Mohammad Abufaraj
    Benjamin Pradere
    Abdulmajeed Aydh
    Ekaterina Laukhtina
    David D’Andrea
    Takashi Saika
    Shahrokh F. Shariat
    International Journal of Clinical Oncology, 2020, 25 : 1881 - 1891
  • [35] New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer
    Conteduca, Vincenza
    Mosca, Alessandra
    Brighi, Nicole
    de Giorgi, Ugo
    Rescigno, Pasquale
    CELLS, 2021, 10 (01) : 1 - 13
  • [36] Incorporating Prognostic Models Into Clinical Practice for Patients With Castration-Resistant Prostate Cancer
    Dorff, Tanya
    Tripathi, Abhishek
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (15) : 2695 - +
  • [37] Improvement of High-sensitivity Inflammation-based Glasgow Prognostic Score by Gastrectomy Is a Favorable Prognostic Factor in Patients with Gastric Cancer
    Takeno, Shinsuke
    Hashimoto, Tatsuya
    Shibata, Ryosuke
    Maki, Kenji
    Shiwaku, Hironari
    Yamana, Ippei
    Yamashita, Risako
    Yamashita, Yuichi
    ANTICANCER RESEARCH, 2014, 34 (10) : 5695 - 5702
  • [38] Utility of High-Sensitivity Modified Glasgow Prognostic Score in Cancer Prognosis: A Systemic Review and Meta-Analysis
    Wu, Tsung-Hsien
    Tsai, Yao-Te
    Chen, Kuan-Yin
    Yap, Wing-Keen
    Luan, Chih-Wei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (02)
  • [39] High-sensitivity modified Glasgow prognostic score (HS-mGPS) Is superior to the mGPS in esophageal cancer patients treated with chemoradiotherapy
    Chen, Peng
    Fang, Min
    Wan, Qiuyan
    Zhang, Xuebang
    Song, Tao
    Wu, Shixiu
    ONCOTARGET, 2017, 8 (59) : 99861 - 99870
  • [40] Cost-effectiveness evaluation of abiraterone in the treatment of patients with castration-resistant prostate cancer who previously received docetaxel.
    Chopra, Akhil
    Gluck, Stefan
    Montero, Alberto J.
    Avancha, Kiran Kumar Venkata Raja
    Lopes, Gilberto
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)